
Annual report 2025
added 02-26-2026
Delcath Systems Cash Flow 2011-2026 | DCTH
Annual Cash Flow Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
22.5 M | -18.7 M | -31.3 M | -25 M | -22.6 M | -22.9 M | -23.7 M | -14.7 M | -15.4 M | - | - | - | -34.1 M | -50 M | -37.4 M |
Depreciation & Amortization |
238 K | 134 K | 128 K | 132 K | 146 K | 167 K | 212 K | 444 K | 310 K | 305 K | 617 K | 958 K | 1.13 M | 1.33 M | 1.04 M |
Accounts Payables |
2.66 M | 961 K | 1.01 M | 2.02 M | 638 K | 1.77 M | 4.53 M | 7.72 M | 3.85 M | 594 K | 284 K | 748 K | 582 K | 939 K | 925 K |
Accounts Receivables |
11.7 M | 10.9 M | 241 K | 366 K | 44 K | 57 K | 21 K | 585 K | 317 K | 403 K | 277 K | 174 K | 349 K | 144 K | - |
Total Inventories |
10.3 M | 6.93 M | 3.32 M | 2 M | 1.41 M | 855 K | 654 K | 858 K | 1.25 M | 660 K | 757 K | 349 K | 719 K | 1.1 M | - |
All numbers in USD currency
Quarterly Cash Flow Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 2.2 M | - | - | - | -9.58 M | - | - | - | -4.26 M | - | -17.6 M | -12.4 M | -6.38 M | - | -16.6 M | -11.7 M | -4.57 M | - | -17.8 M | -13.1 M | -5.23 M | - | -18.3 M | -5.96 M | -2.77 M | - | -12.9 M | -9.28 M | -6.44 M | - | -11.7 M | -8.14 M | - | - | - | - | - | - | - | - | - | - | - | - | -4.49 M | - | - | -21.5 M | -10.9 M | - | -40.7 M | -27.2 M | -14.2 M | - | -23.8 M | -14.3 M | -6.72 M |
Depreciation & Amortization |
100 K | 100 K | 43 K | - | 100 K | 100 K | 29 K | - | 100 K | 100 K | 30 K | - | 100 K | 100 K | 31 K | - | 115 K | 78 K | 39 K | - | 125 K | 92 K | 48 K | - | 100 K | 100 K | 65 K | - | 100 K | 100 K | 120 K | - | 100 K | 100 K | 74 K | - | 100 K | 100 K | 87 K | - | 100 K | 200 K | 196 K | - | 200 K | 300 K | 249 K | - | 300 K | 300 K | 298 K | - | 300 K | 400 K | 322 K | - | 723 K | 456 K | 216 K |
Accounts Payables |
2.13 M | 4.72 M | 1.62 M | 961 K | 937 K | 3.28 M | 1.49 M | 1.01 M | 753 K | 966 K | 2.43 M | 2.02 M | 2.63 M | 2.07 M | 1.24 M | 638 K | 1.19 M | 1.22 M | 1.23 M | 1.77 M | 1.77 M | 1.77 M | 1.77 M | 4.53 M | 4.53 M | 4.53 M | 4.53 M | 7.72 M | 7.72 M | 7.72 M | 7.72 M | 3.85 M | 3.85 M | 3.85 M | 3.85 M | 594 K | 594 K | 594 K | 594 K | 284 K | 284 K | 284 K | 284 K | 748 K | 748 K | 748 K | 748 K | 582 K | 582 K | 582 K | 582 K | 939 K | 939 K | 939 K | 939 K | 925 K | 6.4 M | 6.4 M | 925 K |
Accounts Receivables |
13.8 M | 15.8 M | 13.9 M | 10.9 M | 6.94 M | 3.73 M | 1.56 M | 241 K | 205 K | 127 K | 458 K | 366 K | 537 K | 438 K | 178 K | 44 K | 69 K | 75 K | 75 K | 57 K | 57 K | 57 K | 57 K | 21 K | 21 K | 21 K | 21 K | 585 K | 585 K | 585 K | 585 K | 317 K | 317 K | 317 K | 317 K | 403 K | 403 K | 403 K | 403 K | 277 K | 277 K | 277 K | 277 K | 174 K | 174 K | 174 K | 174 K | 349 K | 349 K | 349 K | 349 K | 144 K | 144 K | 144 K | 144 K | - | - | - | - |
Total Inventories |
10.7 M | 10.5 M | 7.13 M | 6.93 M | 6.64 M | 6.32 M | 3.63 M | 3.32 M | 2.67 M | 2.48 M | 2.34 M | 2 M | 1.93 M | 2.04 M | 2.01 M | 1.41 M | 1.24 M | 1.22 M | 1.11 M | 855 K | 855 K | 855 K | 855 K | 654 K | 654 K | 654 K | 654 K | 858 K | 858 K | 858 K | 858 K | 1.25 M | 1.25 M | 1.25 M | 1.25 M | 660 K | 660 K | 660 K | 660 K | 757 K | 757 K | 757 K | 757 K | 349 K | 349 K | 349 K | 349 K | 719 K | 719 K | 719 K | 719 K | 1.1 M | 1.1 M | 1.1 M | 1.1 M | - | - | - | - |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company Delcath Systems, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Medical devices sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 9.38 | -1.78 % | $ 722 M | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | ||
|
Inogen
INGN
|
$ 6.5 | 1.25 % | $ 173 M | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | ||
|
Stryker Corporation
SYK
|
$ 332.68 | 1.57 % | $ 127 B | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | ||
|
Tandem Diabetes Care
TNDM
|
$ 23.32 | -3.87 % | $ 1.59 B | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | ||
|
Outset Medical
OM
|
$ 3.52 | -0.28 % | $ 53.5 K | ||
|
PAVmed
PAVM
|
$ 8.94 | -3.87 % | $ 64.7 M | ||
|
CONMED Corporation
CNMD
|
$ 36.64 | -1.19 % | $ 1.14 B | ||
|
Electromed
ELMD
|
$ 24.45 | -0.85 % | $ 207 M | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | ||
|
Viemed Healthcare
VMD
|
$ 9.22 | -1.39 % | $ 359 M | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.6 | -10.61 % | $ 32.7 M | ||
|
Aethlon Medical
AEMD
|
$ 2.27 | -2.16 % | $ 3.54 M | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | ||
|
LivaNova PLC
LIVN
|
$ 63.65 | 0.55 % | $ 3.47 B | ||
|
InspireMD
NSPR
|
$ 1.73 | -2.26 % | $ 111 M | ||
|
AdaptHealth Corp.
AHCO
|
$ 11.41 | 0.18 % | $ 1.54 B | ||
|
Penumbra
PEN
|
$ 336.42 | 0.04 % | $ 13.1 B | ||
|
MiMedx Group
MDXG
|
$ 3.94 | -3.9 % | $ 582 M | ||
|
TELA Bio
TELA
|
$ 0.75 | 8.11 % | $ 35.2 M | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | ||
|
Myomo
MYO
|
$ 0.68 | -2.2 % | $ 28.5 M | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | ||
|
Beyond Air
XAIR
|
$ 0.69 | -6.74 % | $ 46.7 M | ||
|
Inspire Medical Systems
INSP
|
$ 50.45 | -1.87 % | $ 1.48 B | ||
|
Xtant Medical Holdings
XTNT
|
$ 0.57 | 0.53 % | $ 76.2 M | ||
|
Pulmonx Corporation
LUNG
|
$ 1.24 | -4.62 % | $ 50.5 M | ||
|
Varex Imaging Corporation
VREX
|
$ 10.78 | 0.84 % | $ 446 M | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M |